• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Guo-lin, XU Ming, DAI De-zai, XI Tao, DAI Yin. Endothelin-NADPH oxidase mediates cardiomyocytes dysfunction caused by H2O2 and interventions by CPU0213[J]. Journal of China Pharmaceutical University, 2011, 42(5): 452-457.
Citation: ZHANG Guo-lin, XU Ming, DAI De-zai, XI Tao, DAI Yin. Endothelin-NADPH oxidase mediates cardiomyocytes dysfunction caused by H2O2 and interventions by CPU0213[J]. Journal of China Pharmaceutical University, 2011, 42(5): 452-457.

Endothelin-NADPH oxidase mediates cardiomyocytes dysfunction caused by H2O2 and interventions by CPU0213

More Information
  • Over-activated NADPH oxidase and endothelin(ET)system are the main mechanism of cardiomyocytes dysfunction.This research mainly focuses on the hypothesis that CPU0213 attenuates cardiomyocytes dysfunction by inhibiting the over-expression of ET-NADPH oxidase.Cardiomyocytes were divided into groups:control, H2O2 group, H89/Bis, APO/DPI, CPU0213 group.The expression of FKBP12.6, SERCA2a and CASQ2 were down-regulated and pPKCε/PKCε,NADPH oxidase and ETAR/ETBR were up-regulated in H2O2 treated group,which implyed the involvement of PKCε.Endothelin receptor antagonist CPU0213 attenuated the abnormal expression of FKBP12.6, SERCA2a and CASQ2 by inhibiting pPKC-NADPH pathway.
  • Related Articles

    [1]SHANG Feiyang, LIU Chengbo, TAN Hongzhou, HE Bing, HE Liqin. Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives[J]. Journal of China Pharmaceutical University, 2024, 55(3): 367-374. DOI: 10.11665/j.issn.1000-5048.2023072901
    [2]DAI Weiguo, TAN Hongzhou, GU Hongxia, HE Bing, HE Liqin, HUANG Peng. Design, synthesis and anti-platelet aggregation activity of paeonol oxime derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(5): 535-541. DOI: 10.11665/j.issn.1000-5048.20220504
    [3]GAO Yang, YIN Wei, LIU Jingchao, KANG Fenghua, JIAN Yanlin, ZHOU Jinpei, HUANG Zhangjian, ZHANG Yihua. Design, synthesis and antiplatelet evaluation of tetramethylpyrazine/chalcone hybrids[J]. Journal of China Pharmaceutical University, 2017, 48(1): 23-30. DOI: 10.11665/j.issn.1000-5048.20170104
    [4]WANG Xiaoli, WANG Zhaoya, WANG Linna, JI Hui, ZHANG Yihua, YIN Jian. Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 158-162. DOI: 10.11665/j.issn.1000-5048.20160205
    [5]FANG Jiangen, WANG Xuliang, LING Jingjing, YIN Wei, XU Jinyi, JI Hui, ZHANG Yihua. Synthesis and antiplatelet aggregation/antioxidant activity of 3-alkyl-benzo[c] selenophen-1(3H)-ones[J]. Journal of China Pharmaceutical University, 2015, 46(5): 552-555. DOI: 10.11665/j.issn.1000-5048.20150506
    [6]YANG Chunyu, HUANG Zhangjian, LING Jingjing, JI Hui, LAI Yisheng, XU Jinyi, PENG Sixun, ZHANG Yihua. Synthesis and evaluation of carbamate-isosorbide-3-n-butylphthalide ring opening derivative trihybrids as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2013, 44(3): 202-206. DOI: 10.11665/j.issn.1000-5048.20130302
    [7]ZHANG Bo-yu, SHAN Jia-qi, LIU Lin, JIAO Bo, SUN Hong-bin. Synthesis and antiplatelet aggregation activities of prasugrel derivatives[J]. Journal of China Pharmaceutical University, 2011, 42(4): 305-309.
    [8]Synthesis and anti-platelet aggregation activity of substituted (E)-1,2-diarylethene compounds[J]. Journal of China Pharmaceutical University, 2010, 41(5): 419-423.
    [9]LI Bao-quan, LI Nian-guang, FENG Feng, TANG Yu-ping, DUAN Jin-ao. Synthesis and anti-platelet aggregation activities of ferulic acid esters[J]. Journal of China Pharmaceutical University, 2009, 40(6): 486-490.
    [10]Synthesis and Antiplatelet Aggregation of N Acylated Tetrahydrobenzylisoquinoline[J]. Journal of China Pharmaceutical University, 1997, (5): 3+6-7.

Catalog

    Article views (1606) PDF downloads (1608) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return